CareDx (CDNA) vs GeneDx (WGS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
CareDx (CDNA) has outperformed GeneDx (WGS) over the past year, gaining 329.7% versus a loss of 43.3%. Over five years, CDNA leads with a -11.2% price change compared with -73.3% for WGS. CareDx is the larger company by market cap ($3.26 billion vs $2.04 billion), about 1.6 times the size.
On valuation, CareDx trades at a lower forward P/E (48.9x vs 57.2x for GeneDx).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CDNA | WGS |
|---|---|---|
| Share price | $63.04 | $68.53 |
| Market cap | $3.26B | $2.04B |
| 1-day change | -1.18% | -4.18% |
| YTD return | +234.61% | -47.31% |
| 1-year return | +329.72% | -43.25% |
| 5-year return | -11.21% | -73.34% |
| P/E ratio (TTM) | 30.60 | — |
| Forward P/E | 48.87 | 57.18 |
| EPS (TTM) | $2.06 | $-3.63 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $72.51 | $170.87 |
| 52-week low | $13.95 | $32.21 |
| Distance from 52-week high | -13.06% | -59.89% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | -6.68% | +36.44% |
| Average volume | 1.28M | 729.57K |
| Shares outstanding | 51.73M | 29.82M |
| Employees | 761 | 1,300 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical/Nursing Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CDNA has outperformed WGS by 373.0 percentage points over the past year.
About CareDx
CDNA stock →CareDx, Inc. provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally.
Health Care · Medical Specialities · 761 employees
About GeneDx
WGS stock →GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services.
Health Care · Medical/Nursing Services · 1,300 employees
CDNA vs WGS FAQ
Which is bigger, CareDx or GeneDx?
CareDx (CDNA) is larger, with a market capitalization of $3.26B compared with $2.04B for GeneDx (WGS).
Which stock has performed better over the past year, CDNA or WGS?
CDNA returned +329.72% over the past 12 months, compared with -43.25% for WGS (price return, excluding dividends). Past performance does not predict future results.
Are CareDx and GeneDx in the same industry?
Both are in the Health Care sector, but in different industries: Medical Specialities for CareDx and Medical/Nursing Services for GeneDx.